Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TIIM Healthcare has developed aiTriage™, an AI-driven digital health platform that leverages heart rate variability and vital sign data to rapidly assess patient risk during chest pain presentations and sepsis. The system enables faster, more accurate triage decisions compared to conventional scoring tools. Clinical studies have shown improved predictive performance over existing models for both cardiac events and sepsis mortality. The company holds exclusive IP rights to a novel Duke-NUS Medical School-developed technology for rapid sepsis mortality assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TIIM Healthcare.